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Suddenly, right in front of us, looms a dark, ungainly blimp... Col-
lision is inevitable.. .hurling us into what turns out to be a thoroughly
unpleasant environment. Everywhere we look are scenes of destruction:
maimed molecules ofvarious kinds, shapeless debris, hal/-recognizable
pieces of bacteria and viruses, fragments of mitochondria, membrane
whorls, damaged ribosomes, all in the process ofdissolving away before
our very eyes.
from "A Guided Tour of the Living Cell"






In his Nobel LeCture, Chrisrian de Duve, Andrew W. Mellon
Professor of The Rockefeller University, likened himself to a
character in a tale who "traveled the whole of Sweden, from
SHne to Lappland, on the wings of a white gander. I, too," he
said, "have made a wonderful journey, using, like Nils Hol-
gersson, an unconventional mode of travel." For thirty-five
years Dr. de Duve has roamed the living cell. Unlike Nils Hol-
gersson's, the landscape he has traversed was largely uncharted
when he set Out.
For a century following the recognition of the cell as the basic
unit of life, biologists, bumping always against the limits of
the light microscope, could distinguish within the cellular bor-
der only a nucleus and some shadowy forms surrounded by a
mysterious jelly. Then, in 1944, Albert Claude, a Belgian sci-
entist working at what was then The Rockefeller Institute for
Medical Research, in collaboration with Keith R. Porcer and
Ernest F. Fullam, published the first electron micrograph of a
cell. "The structural complexities that were revealed," says Dr.
de Duve, "exceeded anything that had been imagined." Two
years later, Claude published two papers collectively titled
"Fractionation of Mammalian Liver Cells by Differential Cen-
trifugation," in which he described a method for separating cel-
lular structures intact, making them accessible for study of
their biological activity. The age of modern cell biology had be-
gun.
The studies that began with Claude, who died last year in
Belgium at the age of eighty-four, yielded, within one gener-
ation, an essentially complete catalogue of the cell's working
parts, achieved by a small band of pioneers who refined and ex-
tended his techniques. Among them was George Palade, now
at Yale University, who spent twenty-eight years at Rockefel-
ler, the early ones with Claude. During that time, working
with the eleCtron microscope and fractionation techniques, he
isolated and explained mitochondria, the cell's energy-conven-
ing power plants, and discovered ribosomes, the protein "fac-
tories. "
Another explorer was Christian de Duve, a Belgian like
Claude, who was lured into cell biology by "a chance observa-
tion." The passage at the opening of this profile is from a book




Books, Inc., in collaboration with The Rockefeller University
Press. The "unpleasant environment" it describes is a lysosome.
Central to cellular function, lysosomes are minuscule sacs - or-
ganelles - filled with powerful enzymes that break down the
substances ingested by cells, performing the critical tasks of
digestion and waste disposal. Lysosomes were identified by Dr.
de Duve, at the Catholic University of Louvain, in 1955.
In 1974 Albert Claude, Christian de Duve, and George Pa-
• lade shared the Nobel Prize in Physiology or Medicine for their
"discoveries concerning the structural and functional organi-
zation of cells."
In his Rockefeller laboratory, which he established in 1962,
reflecting on the events that led him to lysosomes, Dr. de Duve
smiles and confides, "I wasn't attracted to science as a boy. Al-
though I thought medicine would be a rewarding career, 1
dreaded the ordeal of chemistry and biology. But everything
changed when I entered medical school at Louvain in 1934.
The head of physiology there, Joseph Bouckaert, was a true sci-
entist. 1 walked into his laboratory and 1 was hooked.
"I began by working with a group studying insulin. 1 be-
came so involved 1 almost didn't finish my clinical training. I
even made a discovery, or, rather, a rediscovery; I found glu-
cagon, an insulin antagonist, as a contaminant of Lilly insulin.
I had unearthed this 'impurity' - it is really an important hor-
mone - in the old literature, where it had been buried after
crystalline insulin was found to be free of it. I came to the con-
clusion that glucagon must have reappeared surreptitiously as
a result of a change in the procedure for purifying insulin. This,
at least, was the only way 1 could account for a major contra-
diction between my own experimental results and much of the
recent American Ii terature. By then, however, the war had
started and I couldn't test my hypothesis. The day my country
was liberated - well, no, the second day, the first day, ofcourse,
everybody gOt drunk ~ I went to an American army post and
got some Lilly insulin. We checked it in the lab and found that
it did indeed contain glucagon. I felt like Le Verrier when he
discovered Neptune."
After the war, convinced that chemistry rather than physi-
ology was the path to his goal, which was to elucidate the
mechanisms of insulin action in the liver, Dr. de Duve, who by
then had added a chemical degree to his medical degree, went
to Stockholm to study with "the coming man in biochemistry,"
Hugo Theorell. Two years later, equipped with "the tools of
the trade," he went to Washington University in St. Louis.
"Carl and Gerty Cori were then the big experts in carbohydrate
metabolism," he says, "and I asked if they would let me work
with them for six months before I had to be back in Louvain,
where I had just received an appointment." At Washington
University, he and Earl Sutherland showed that glucagon is
made by the alpha cells of the islets of Langerhans in the pan-
creas and is presumably a hormone. "It was a nice piece ofwork.
I've been very lucky in picking teachers." (Carl and Gerty Cori
won a Nobel Prize in 1947, Theorell in 1955, and Sutherland
in 1971.)
PECUliAR ENZ¥MES AND DENSE BODIES
Back at Louvain, working with Gery Hers, his first student and
continuing colleague, Dr. de Duve set up a small biochemistry
laboratory and started a study of an enzyme that was assumed
to be involved in insulin action. Enzymes are proteins that
speed up or otherwise modify biological activity. In the course
of trying to purify the enzyme glucose 6-phosphatase, they kept
losing it. When they made the medium more acid to get the
enzyme out of solution, they,couldn't get it back in solution
again by neutralizing the acid, which, says Dr. de Duve, was
not normal behavior for a soluble protein.
Earlier, on his way home from St. Louis, Dr. de Duve had
stopped off in New York to pay his respects to his countryman
Albert Claude, who gave him copies of the papers on cell frac-
tionation. Reading them in Louvain, he thought he saw a clue
to the mystery of the missing enzyme. As he explains: "Claude
had shown that cell particles will agglutinate at the acid level
we had exposed our enzyme to. It occurred to me that perhaps
the enzyme might be bound to a structure. I decided to try
Claude's methods to see if I could find Out where it was." At
that point he also was able to seek some advice from Claude
himself, who had shortly before returned to Belgium to direct
the Bordet Institute.
Up to that time, the methods used by biochemists to extract
cells usually broke the more fragile intracellular structures.
Claude had found a way to disrupt cells gently in a liquid me-
dium to yield cell preparations still containing unbroken, func-
tional organelles. The suspension, or homogenate, was then
spun in centrifuges at successively higher speeds to separate and
isolate the particles by size and density.
Dr. de Duve found his enzyme bound to structures called
microsomes, which are fragments of internal cell membranes.
Glucose 6-phosphatase was one of the first enzymes to be local-
ized, and the first in microsomes, for which it is still the
marker. Meanwhile, during the hunt, he observed another en-
zyme behaving peculiarly. This was the chance observation, in
1949, that would induce him to abandon insulin in favor of cell
biology.
"While looking for glucose 6-phosphatase," he explains, "we
also systematically measured another enzyme, called acid phos-
phatase. This enzyme held no interest for me per se but it had
to be checked beca~se it could give false positives. To our sur-
prise, its activity was a tenth of what we expected on the basis
of previous assays." Curious, he resisted the temptation to dis-
card these results as a technical error. He decided to go after
acid phosphatase. Its trail ended in the cell organelles that he
named lysosomes.















































In the process ofdifferential
centrifugation, cells are ground
in a solution and the resulting
homogenate (misnamed because it
is anything but homogeneous)
is spun in a centrifuge at pro-
gressively higher revolutions
per minute to separate different
particles. Ina final step I called
density-gradient centrifugation,
crude fractions containing
mostly mitochondria are subjected
to very high centrifugal force
in a medium ofgraded density
which separates the mitochon-
dria, lysosomes, and peroxisomes.
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de Ouve's "white gander," and Qn biochemical identification
marks, because lysosomes do not have consistent structural
characteristics like most other organelles. There can be
hundreds of lysosomes within a single cell, possessing a bewil-
dering array of sizes and shapes depending on the kind and
amount of material they have ingested and on the stage of the
digesting (lysing) process. The positive identification of lyso-
somes cook years of research, years during which Dr. de Ouve
postulated and proved a number of theories concerning enzyme
distribution and he and his lab mates studied the centrifugation
process intensively and developed innovative applications and
designs.
While Dr. de Ouve was centrifuging, other scientists were
improving the infant technology of the electron microscope. In
1955, with the help of Alex Novikoff of the Albert Einstein
College of Medicine, Dr. de Ouve obtained the first electron
micrographs of a cell fraction containing lysosomes and,
thereby, his first glimpse of what his "chiledren" looked like. In
the liver, they corresponded to the "dense bodies" described by
microscopists. Later, using the same biochemical approach, he
and his colleagues were able to isolate and characterize a differ-
ent kind of organelle, the peroxisome, which they subsequently
identified with the entities named microbodies by the electron
microscopist who first saw them. These organelles form the ba-
sis of much of the current research in Dr. de Ouve's Rockefeller
laborarory.
AIR BRIDGE TO MECCA
The problems Dr. de Ouve grappled with in the 1950s were not
solely intellectual. The main business at Louvain was the train-
ing of physicians, and support for basic science in those years
was very limited. As a member of the medical faculty, he
taught hundreds of students each year and gave hundreds of ex-
ams, while directing a growing laboratory for which he was ex-
pected to raise the bulk of the funds. "Scientific papers I wrote
evenings," he remembers, "in a house with four young chil-
dren. I was a one-man band."
From time to time he attended scientific meetings in the
United States and would revisit Rockefeller. "It was the place
where most of the major work in my field was being done," he
says. "To me it was Mecca. By then, the institute had become
a graduate university and Oetlev Bronk, an extraordinary man,
was president. Palade was working with Philip Siekevitz doing
the definitive studies in protein synthesis, James Hirsch and
Zanvil Cohn were doing the most important work anywhere on
lysosomes in immune cells, Stanford Moore and William Stein
were developing amino acid analysis of enzymes. It was easy ro
see the reasons for the University's success: excellent people free
to pursue their interests."
On one of his visits, Dr. de Ouve remarked to George Palade
that he would love co work at Rockefeller. "Palade, I remem-
ber, just looked at me and said, 'Are you serious?' To my utter
surprise, not long after I returned home Bronk flew over to Bel-
gium and offered me a job. Well, Louvain wasn't toO happy
about that, so we worked out a compromise. I would 'tempo~
rarily' run both labs, at Rockefeller and Louvain. I'm still doing
it! I have a very patient wife, who also happens ro love New
York. Over the years there has been an air bridge, with Louvain
people coming to Rockefeller and my Rockefeller colleagues
and students going to Belgium. Altogether, a very rich ex-
change."
FIRST PHOTO:
Drs. Miklos Muller, left,
Thomas Gorrell, seated. and
Martin Weiss at the anaerobic
chamber. Anaerobes are orga-
nisms that live in the absence of
oxygen. Among them are tricho-
monads, single-cdled protozoa in
which Dr. Miiller identified
struC"tures called hydrogenosomes.
SECOND PHOTO:
Dr. de Duve and longtime
assistant Armando Pelaschier at
, the Beau/ay centrifuge, a fully
automated instrument designed
by Dr. Henri Beau/ay in Dr. de
Olive's laboratory in Belgillm
and built at Rocke/eller.
THIRD PHOTO:
Drs. Paul Lazarow, right,
Yukio FUjiki, left. and Richard
Rachubimki dismss new findings
on peroxisomes, cell structures
first described in Dr. de Duve's
laboratory .
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Carl Beyer, who began his
Rockefeller career as a doctoral
student. His current research
centers on the biochemistry and
cell biology of lymphocytes,
white cells of the immune-defense
system.
I
Margaret Perkins holds a labo-
ratory dish containing red
blood cells infected with malaria
parasites. She has identified
the proteins on the blood cells to
which the parasites attach
and is now characterizing the
proteins on the parasite cell sur-
face involved in the binding
proces's.
THE COMMON THREAD
The discovery of lysosomes was followed by the characterization
of peroxisomes, named for the fact that they produce hydrogen
peroxide during their metabolic activity. They were found the
way lysosomes were, by tracking an oddly behaving enzyme to
its source. "Like mitochondria," says Dr. de Duve, "peroxi-
somes convert fuel to energy, but in an essentially wasteful
manner. Their primitive form, mode of action, and broad dis-
tribution across species have led us to believe that they predate
mitochondria. What we are seeing may be evolutionary descen-
dants of a single ancestral particle that was present in the first
eukaryotic cell (a cell with a true nucleus) from which all plants
and animals are believed to have originated."
Paul Lazarow, who joined Dr. de Duve's Rockefeller labo-
ratory as a graduate student in 1968, became fascinated by per-
oxisomes. "Although they are present in most and possibly all
cell types and are very abundant in the liver," he says, "very lit-
tle was known about their function or biogenesis; how their
proteins are made and how the proteins are transported to and
packaged in the organelle, a process that turns out to work dif-
ferently in peroxisomes than in other organelles." His thesis re-
search provided the answers to where in the liver cell the
enzyme catalase is made and by what pathway it is conveyed to
its peroxisomal abode.
After postdoctoral stints in Italy and at Stanford University,
Dr. Lazarow returned to Rockefeller as a faculty member in
1975. "At that time," he says, "there were hints in the litera-
ture that peroxisomes might be involved in lipid (fat) metab-
olism; clofibrate and other drugs which are given to patients to
lower blood lipid levels induced the proliferation of peroxi-
somes in experimental rats. We decided to investigate, and to
our surprise found that peroxisomes were actually involved in
fatty acid catabolism (metabolic breakdown)."
Concurrent with continuing studies of the biogenesis of per-
oxisomes, Dr. Lazarow is collaborating in an investigation of
Zellweger's Syndrome, a very rare condition of infants born
with no peroxisomes. "These children," he says, "live only a few
months. They have abnormal lipid deposits and abnormal
neural development. We're looking at what goes wrong when
an organelle is missing. Obviously, this will give us informa-
tion about what the organelle is doing when it's present."
Miklos Muller, from Hungary, was invited to join the lab-
oratory when Dr. de Duve heard him report at a scientific meet-
ing in London in 1963. "I had found lysosomes as the major
digestive structure in protozoa," he says, "and in those days no
One associated lysosomes with such primitive single-celled or-
ganisms. Dr. de Duve was interested in lysosomes in protozoa.
I was interested in learning more biochemistry, and where bet-
ter to do it than with de Duve, I thought I would stay only a
year. Then we found peroxisomes in protozoa. A few years
later, we found an organelle totally new to us, hydrogeno-
somes,"
The discovery of hydrogenosomes resulted from a project be-
gun with Donald Lindmark, another member of the group at
the time, to find an experimental organism that would have
peroxisomes but no mitochondria. "Through srudies of elec-
tronmicroscopic images and our knowledge of comparative bio-
chemistry," says Dr. Muller, "we came upon what we thought
were likely candidates, a group of protozoa called trichomon-
ads. They contained structures that looked like peroxisomes
and their enzymes looked like they might be peroxisomal en-
zymes. But when I started my cell fractionation everything
turned upside down. We found our that this organelle was
making hydrogen, something done among animals, it turns
out, by only trichomonads and one other small group of anaer-
obic (non oxygen-breathing) protozoa. So we named the organ-
elles hydrogenosomes. What is their ancestry, their position in
evolution we don't know, but we do know that among the tri-
chomonads, T. vaginalis causes one of the most widespread sex-
ually transmitted diseases in the United States.
"For a number of years there had been a drug on the market,
metronidazole, that worked very well in the treatment ofT. va-
ginalis, but its mode of action was unknown. We began to use
the drug as a biochemical tool to understand how the organism
works, which of course taught us a lot about how the drug
works; its toxicity results from interaction with the enzymes in
hydrogenosomes. At that time metronidazole was under attack
as a possible carcinogen. Since it's the only effective drug for a
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Electron microscopist Helen Shio.
The instrument she works, one
ofa battery ofdifferent kinds of
microscopes in the laboratory,
is capable ofa 200, 000 fold
magnification.
very prevalent and disrressing problem, it was very useful to
learn that its potential dangers were vastly exaggerated."
The search for understanding of cells remains the underlying
basis of the laboratory's research. Just as the search has some-
times led into unexpected byways, it has also attracted scien-
tists from seemingly unrelated areas. Carl Beyer's is
immunology. When he started working in the lab, in 1974,
immune cells were among many kinds of cells being examined
• structurally and biochemically. Although his work now focuses
primarily on the components of the surface membranes of white
cells that activate immune responses, he thinks of himself as a
cell biologist as well as an immunologist. "Maybe I look like an
odd thumb sticking up," he laughs, "but the way I feel, cells
are cells." In another part of the lab, the cells Margaret Perkins
studies are also rather specialized, red blood cells that have been
invaded by malaria parasites.
"The common thread," Dr. de Duve explains, "is a common
approach using the same multidisciplinary technology." To the
methods of fractionation, microscopy, and biochemistry the
laboratory has now added the new technologies of molecular bi-
ology, through which scientists seek to understand biological
activity on the most intimate level, including what goes on in
the place where those activities are programmed on the mole-
cules of DNA: the nucleus. "The holy of holies," Dr. de Duve
calls it.
SICK CELLS
In his new book, Dr. de Duve states: "Now that medical in-
vestigators are turning into subcellular and molecular detec-
tives they are beginning to find out that a great many diseases
are nothing but the manifestations of some digestive disturb-
ance affecting certain cells... Dyspepsia, hyperacidity, consti-
pation, and other digestive upsets are the common lot of
mankind ... Yet these troubles are nothing compared with the
digestive ills that afflict cells."
The most dramatic examples of cellular "constipation" -ly-
sosomal overloading - are caused by genetic deficiencies ofsome
lysosomal enzymes. More than twenty-five such deficiencies
have been found. Like Tay-Sachs disease, the best known, they
often cause severe mental retardation and early death. Arterios-
clerosis is also a form of cellular overloading, as are some kidney
diseases. By contrast, when lysosomes unload where they
shouldn't results can include rheumatoid arthritis, gout, and
silicosis. In tuberculosis and leprosy, the lysosomes of immune
cells fail to digest invading bacteria. All infections at base re-
sult from lysosomal failure .
In 1975 Dr. de Duve founded The International Institute of
Cellular and Molecular Pathology, in Brussels, of which he is
president. ICP is Dr. de Duve's "dream come true," his homage
to his homeland and to Rockefeller, of which it is a replica on
a smaller scale but with the same principles of untrammeled re-
search in the service of human knowledge and health. One of
the projects at ICP involves the designing of biological carriers
to take drugs to lysosomes. "The idea," he says, "is to direct
toxic chemicals to cells that one wishes to destroy - cancer cells,
for example - by means of carrier substances that are taken up
selectively by thest: cells. Knowledge of lysosomes has allowed
the design ofefficient targeted preparations of this kind that are
now under clinical trial."
The medical applications that may derive from deeper in-
sight into the intimate processes of cells are only beginning to
be explored. The implications seem almost limitless. As Dr. de
Duve comments: "The first great medical discoveries of the past
century were made without the help of much understanding of
cellular and molecular mechanisms. From the new findings of
cellular and molecular biology will come, I am convinced, a
second, even more remarkable era of discoveries. My generation
has witnessed a revolution of knowledge that will be talked
about a thousand years from now. I feel very privileged to have
participated in it JUSt a little."
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